Omega Therapeutics, Inc. (OMGA) Tops Q2 EPS by 7c
Tweet
Share
E-mail
Get Alerts OMGA Hot Sheet
Join SI Premium – FREE
Omega Therapeutics, Inc. (NASDAQ: OMGA) reported Q2 EPS of ($0.30), $0.07 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $2.13 million versus the consensus estimate of $956.14 thousand.
For earnings history and earnings-related data on Omega Therapeutics, Inc. (OMGA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- TechCreate Group faces NYSE American delisting proceedings
- Circle board member resigns after nearly 13 years of service
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
